Beijing Youshilin Science and Technology Development

Beijing Youshilin Science and Technology Development is a Chinese biotechnology company that operates as a wholly-owned subsidiary of Gan & Lee Pharmaceuticals. Based in Beijing, the company is primarily involved in the research, development, and commercial distribution of insulin products, including recombinant human insulin and various insulin analogs. Its commercial portfolio features key products such as insulin glargine, insulin lispro, and insulin aspart, which are essential treatments for patients with Type 1 and Type 2 diabetes. The company plays a vital role in the technical advancement and market distribution of the parent company's metabolic disease treatments. Beijing Youshilin supports Gan & Lee's global expansion efforts by ensuring high standards in biopharmaceutical production and clinical development.